authors
- Clemons, Mark J
- Cochrane, Brandy
- Califaretti, Nadia
- Chia, Stephen KL
- Dent, Rebecca Alexandra
- Song, Xinni
- Robidoux, Andre
- Pond, Gregory
- Parpla, Sameer
- Pritchard, Kathleen
- Levine, Mark Norman
Randomized phase II placebo-controlled trial of fulvestrant plus vandetanib in postmenopausal women with bone only or bone predominant, hormone receptor-positive metastatic breast cancer (MBC): OCOG Zamboney study-NCT00811369.
Conference Paper
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- May 20, 2013
has subject area
- 1103 Clinical Sciences (FoR)
- 1112 Oncology and Carcinogenesis (FoR)
- Oncology & Carcinogenesis (Science Metrix)
published in
- Journal of Clinical Oncology Journal